TEX10 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.94295707195624E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.18469999998982E-06 |
Normal-vs-Stage2 |
1.017770E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.003200E-03 |
Stage1-vs-Stage2 |
9.083200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.380200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.737600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.20179488161921E-11 |
Normal-vs-AfricanAmerican |
2.266400E-01 |
Normal-vs-Asian |
1.53839999994521E-06 |
Caucasian-vs-AfricanAmerican |
9.551800E-01 |
Caucasian-vs-Asian |
4.614100E-02 |
AfricanAmerican-vs-Asian |
6.234600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.88219999994488E-06 |
Normal-vs-Female |
2.86329999710233E-08 |
Male-vs-Female |
9.790600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.025600E-04 |
Normal-vs-Extreme_Weight |
2.10840000003376E-06 |
Normal-vs-Obese |
3.013000E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.051800E-01 |
Normal_Weight-vs-Obese |
1.188250E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.808120E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.98070000401174E-08 |
Normal-vs-Age(41-60Yrs) |
2.384300E-04 |
Normal-vs-Age(61-80Yrs) |
7.52210005394716E-09 |
Normal-vs-Age(81-100Yrs) |
3.128000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.297910E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.491560E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.342000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.160600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.468800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.460200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.665400E-01 |
Normal-vs-Grade 3 |
4.063200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.958200E-01 |
Grade 2-vs-Grade 4 |
4.665400E-01 |
Grade 3-vs-Grade 4 |
4.063200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.23919996486421E-09 |
Normal-vs-N1 |
2.583000E-03 |
N0-vs-N1 |
1.262020E-01 |
|
|